Table 2 MEFV mutations in the study groups. n (%)
From: Colchicine treatment can be discontinued in a selected group of pediatric FMF patients
Genotype | Group 1 N = 21 | Group 2 N = 30 | total N = 51 | P value |
|---|---|---|---|---|
M694V/0 | 14 (67) | 9 (30) | 23 (45) | 0.0096 |
M694V/V726A | 0 (0) | 9 (30) | 9 (18) | 0.0057 |
M694V/A744S | 0 (0) | 1 (3) | 1 (2) | 0.3981 |
Two pathogenic variants (Total) | 0 (0) | 10 (33) | 10 (20) | 0.0032 |
M694V/E148Qa | 3 (14) | 6 (20) | 9 (18) | 0.5983 |
V726A/E148Qa | 2 (10) | 1 (3) | 3 (6) | 0.3551 |
No mutations | 1 (5) | 3 (10) | 4 (8) | 0.4935 |
N/A | 1 (5) | 1 (3) | 2 (4) | 0.7959 |